The board of directors of Bloomage BioTechnology Corporation Limited announced the changes: Mr. Guo Jiajun, an ex-executive Director and the ex-chief executive officer of the company, has been re-designated as a non-executive Director and resigned from the Chief Executive Officer of the company with effect from June 18, 2012. After the re-designation, Mr. Guo is responsible for monitoring the performance of the company and providing suggestion for the development of the Group. Mr. Guo has entered into a non-executive director's service contract with the company for a term of two years commencing on June 18, 2012. Ms. Liu Aihua has been appointed as an executive Director and the Chief Executive Officer of the company with effect from June 18, 2012. Before joining the Group, Ms. Liu was the vice-president of Shandong Biopharmaceuticals Research Institute during the period between August 1998 and December 2001. Ms. Liu would be responsible for the day-to-day management of the Group's operation and strategic development. Mr. Jin Xuekun has been appointed as an independent non-executive Director of the company with effect from June 18, 2012. With effect from June 18, 2012, Mr. Zhang Fuping will resign as a member of the audit committee of the company and Mr. Jin Xuekun will be appointed as a member of the Audit Committee. With effect from June 18, 2012, Ms. Zhao Yan and Ms. Zhan Lili will resign as a member of the nomination committee of the company and Ms. Liu Aihua and Mr. Jin Xuekun will be appointed as a member of the Nomination Committee. With effect from 18 June 2012, Ms. Zhan Lili will resign as the chairman and a member of the remuneration committee of the company. Mr. Guo Jiajun and Mr. Zhang Fuping will resign as a member of the Remuneration Committee. Mr. Jin Xuekun will be appointed as the chairman and a member of the Remuneration Committee and Ms. Wang Aihua and Mr. Qin Bin will be appointed as a member of the Remuneration Committee.